Legacy of Life Hawaii Utilizes Paragonix LUNGguard and LIVERguard for Donor Organs in First Transport from Hawaii to California

First use of Advanced Organ Preservation (AOP) technology in Hawaii allows donor lungs and liver to be successfully transported over 2300 miles

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Paragonix Technologies, Inc. achieves a historic milestone in Hawaii with the first-ever utilization of its advanced lung preservation technology, the Paragonix LUNGguard™ system, which protected, monitored and geo-tracked a pair of donor lungs throughout its lengthy voyage to California. The donor organ recovery was managed by the expert staff of Legacy of Life Hawaii, a nonprofit Organ Procurement Organization (OPO) and the only organization in Hawaii federally designated to recover organs and tissue for transplant. Legacy of Life Hawaii works closely with island hospitals to procure and place donor organs for patients in need.

“We strive to offer new, innovative technologies to our transplant center partners in order to deliver the best possible outcomes for the patients we serve,” said Leonard Licina, CEO of Legacy of Life Hawaii. “Adopting this advanced preservation technology, as well as the additional clinical support offered by Paragonix, aids our mission to save and enhance lives through the recovery of organs for transplant.”

In addition to the use of Paragonix’s lung preservation technology, Legacy of Life recently adopted the LIVERguard™ Donor Liver Preservation System. As part of a second, more recent organ donation, a donor liver was protected using the Paragonix LIVERguard for the transport from Hawaii to a transplant center in California.

First of its kind, the Paragonix LUNGguard™ and LIVERguard devices are FDA-cleared donor lung and liver transportation. These devices present major advancements over the current ice-and-cooler practice traditionally used. The devices provides a rigid, protective outer structure designed for physical safety, and the system also incorporates proprietary cooling technology that ensures thermal protection for donor lungs and liver. All Paragonix devices allow users to access critical digital data that monitor and track the donor organ in real-time.

“It is those extreme and complex medical situations that inspire our team at Paragonix to go above-and-beyond for both recipient patients and donor patients. The successful transportation of a preserved donor organ from Legacy of Life Hawaii to California highlights the challenges Organ Procurement Organization and Transplant Centers must overcome in order to safely deliver the gift of a donor organ to an awaiting patient. We are immensely proud to play a part in these life-saving procedures,” said Dr. Lisa Anderson, President & CEO of Paragonix Technologies. “Our preservation technologies such as LUNGguard and LIVERguard are designed to help the transplant community confidently overcome these challenges by providing FDA-cleared preservation devices that offer real-time insights into the environmental conditions and location of the organ.” For more information about Paragonix, visit www.paragonix.com.

About Paragonix Technologies

Paragonix Technologies is a leading provider of Advanced Organ Preservation (AOP) devices that safeguard donor organs during the journey between donor and recipient patients. Our FDA-cleared and CE-marked devices incorporate clinically proven and medically trusted cold preservation techniques that allow unprecedented physical and thermal protection to the organ in transit. Every Paragonix AOP device natively integrates with our novel digital app, delivering real-time organ tracking data and monitoring logistics for transplant teams seeking a secure and centralized solution.

Connect with us on LinkedIn: Paragonix Technologies
Follow us on Twitter: @ParagonixSherpa
Like Us on Facebook: Paragonix SherpaPak

L-408 Rev. 0